These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 16313254
1. Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: potential role in subcutaneous adipocyte apoptosis. Domingo P, Vidal F, Domingo JC, Veloso S, Sambeat MA, Torres F, Sirvent JJ, Vendrell J, Matias-Guiu X, Richart C, HIV-FRS Study Group. Eur J Clin Invest; 2005 Dec; 35(12):771-80. PubMed ID: 16313254 [Abstract] [Full Text] [Related]
2. Switching to nevirapine decreases insulin levels but does not improve subcutaneous adipocyte apoptosis in patients with highly active antiretroviral therapy-associated lipodystrophy. Domingo P, Matías-Guiu X, Pujol RM, Domingo JC, Arroyo JA, Sambeat MA, Vázquez G. J Infect Dis; 2001 Nov 01; 184(9):1197-201. PubMed ID: 11598845 [Abstract] [Full Text] [Related]
3. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy. Giralt M, Domingo P, Guallar JP, Rodriguez de la Concepción ML, Alegre M, Domingo JC, Villarroya F. Antivir Ther; 2006 Nov 01; 11(6):729-40. PubMed ID: 17310817 [Abstract] [Full Text] [Related]
4. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers. Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H. Scand J Immunol; 2008 Dec 01; 68(6):652-60. PubMed ID: 19055701 [Abstract] [Full Text] [Related]
5. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro. Lagathu C, Bastard JP, Auclair M, Maachi M, Kornprobst M, Capeau J, Caron M. Antivir Ther; 2004 Dec 01; 9(6):911-20. PubMed ID: 15651750 [Abstract] [Full Text] [Related]
6. Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy. Ostrowski SR, Katzenstein TL, Pedersen M, Høyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H. Scand J Immunol; 2006 Jun 01; 63(6):478-86. PubMed ID: 16764702 [Abstract] [Full Text] [Related]
7. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients. Jan V, Cervera P, Maachi M, Baudrimont M, Kim M, Vidal H, Girard PM, Levan P, Rozenbaum W, Lombès A, Capeau J, Bastard JP. Antivir Ther; 2004 Aug 01; 9(4):555-64. PubMed ID: 15456087 [Abstract] [Full Text] [Related]
8. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. Aukrust P, Müller F, Lien E, Nordoy I, Liabakk NB, Kvale D, Espevik T, Froland SS. J Infect Dis; 1999 Jan 01; 179(1):74-82. PubMed ID: 9841825 [Abstract] [Full Text] [Related]
9. In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis. Miró O, Villarroya J, Garrabou G, López S, Rodríguez de la Concepción M, Pedrol E, Martínez E, Giralt M, Gatell JM, Cardellach F, Casademont J, Villarroya F. Antivir Ther; 2005 Jan 01; 10(8):945-51. PubMed ID: 16430200 [Abstract] [Full Text] [Related]
10. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Epple HJ, Schneider T, Troeger H, Kunkel D, Allers K, Moos V, Amasheh M, Loddenkemper C, Fromm M, Zeitz M, Schulzke JD. Gut; 2009 Feb 01; 58(2):220-7. PubMed ID: 18936106 [Abstract] [Full Text] [Related]
11. Elevated levels of circulating intercellular adhesion molecule 1 and tumor necrosis factor alpha in the serum of children vertically infected with HIV-1. Obregón E, Börner C, Navarro J, Gurbindo MD, Fernández-Cruz E, Muñoz-Fernández MA. Pediatr AIDS HIV Infect; 1996 Dec 01; 7(6):413-7. PubMed ID: 11361498 [Abstract] [Full Text] [Related]
12. The IL-6 system in HIV-1-infection and in HAART-related fat redistribution syndromes. Saumoy M, López-Dupla M, Veloso S, Alonso-Villaverde C, Domingo P, Broch M, Miranda M, Coll B, Saurí A, Vendrell J, Richart C, Vidal F. AIDS; 2008 Apr 23; 22(7):893-6. PubMed ID: 18427208 [Abstract] [Full Text] [Related]
13. Inhibition of tumor necrosis factor-alpha reduces alveolar septal cell apoptosis in passive smoking rats. Zhang C, Cai S, Chen P, Chen JB, Wu J, Wu SJ, Zhou R. Chin Med J (Engl); 2008 Apr 05; 121(7):597-601. PubMed ID: 18466678 [Abstract] [Full Text] [Related]
14. Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients. Antinori A, Trotta MP, Nasta P, Bini T, Bonora S, Castagna A, Zaccarelli M, Quirino T, Landonio S, Merli S, Tozzi V, Di Perri G, Andreoni M, Perno CF, Carosi G. Antivir Ther; 2006 Apr 05; 11(2):233-43. PubMed ID: 16640104 [Abstract] [Full Text] [Related]
15. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy. Sevastianova K, Sutinen J, Kannisto K, Hamsten A, Ristola M, Yki-Järvinen H. Am J Physiol Endocrinol Metab; 2008 Jul 05; 295(1):E85-91. PubMed ID: 18430964 [Abstract] [Full Text] [Related]
16. Mitochondrial DNA assessment in adipocytes and peripheral blood mononuclear cells of HIV-infected patients with lipodystrophy according to a validated case definition. Casula M, van der Valk M, Wit FW, Nievaard MA, Reiss P. HIV Med; 2007 Jan 05; 8(1):32-7. PubMed ID: 17305930 [Abstract] [Full Text] [Related]
17. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals. Tornero C, Alberola J, Tamarit A, Navarro D. Clin Microbiol Infect; 2006 Jun 05; 12(6):555-60. PubMed ID: 16700705 [Abstract] [Full Text] [Related]